Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
Summary
This condition describes an adverse reaction to an unspecified systemic anti-infective or antiparasitic medication during the initial encounter. It includes unintended harmful effects from these agents, which may impact patient safety or treatment outcomes.
Causes
Adverse effects can result from allergic reactions, drug interactions, incorrect dosing, or idiosyncratic responses to anti-infective/antiparasitic drugs. Underdosing may occur due to subtherapeutic administration or formulation errors.
Risk Factors
- Concurrent use of multiple medications increasing interaction risk.
- Pre-existing renal or hepatic impairment affecting drug metabolism.
- History of allergic reactions to similar drug classes.
- Lack of proper medication monitoring or dosage adjustments.
Symptoms
- Nausea, vomiting, or gastrointestinal distress.
- Dizziness, confusion, or central nervous system effects.
- Skin rashes, itching, or hypersensitivity reactions.
- Signs of underdosing, such as unresolved infection or parasite persistence.
Diagnosis
Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, organ function). Documentation should clarify the specific agent involved when possible.
Treatment Options
Management depends on the severity of the reaction and may include discontinuing the offending drug, supportive care, or specific antidotes if available. Dosage adjustments or alternative therapies may be considered.
Prognosis and Follow-Up
Prognosis varies based on the reaction severity and promptness of treatment. Follow-up ensures resolution of symptoms and monitors for delayed effects or recurrence.
Complications
- Severe allergic reactions (e.g., anaphylaxis).
- Organ damage from toxic exposure.
- Treatment failure due to underdosing or resistance.
Lifestyle & Prevention
- Verify medication allergies and interactions before prescribing.
- Educate patients on proper dosing and adherence.
- Monitor renal/hepatic function in high-risk individuals.
When to Seek Professional Help
Seek immediate care for severe symptoms (e.g., difficulty breathing, swelling, or altered mental status) or if symptoms worsen despite initial management.
Tips for Medical Coders
Document the specific agent when known, as "unspecified" is used only when the drug cannot be identified. Include details on the encounter type (initial) and any contributing factors (e.g., allergies, interactions).
Medical Policies and Guidelines
Related policies from health plans
T37.95XA policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.